T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL TO EVALUATE THE TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQ...

por Abbs, Brandon, Bugarski-Kirola, Dragana, (Cathy) Liu, I-Yuan, Darwish, Mona, Stankovic, Srdjan
Publicado 2020

Effects of adjunctive pimavanserin and current antipsychotic treatment on QT interval prolongation in patients with schizophrenia

por Bugarski-Kirola, Dragana, Nunez, Rene, Odetalla, Ramzey, Liu, I-Yuan, Turner, Mary Ellen
Publicado 2022

T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSY...

por Bugarski-Kirola, Dragana, Nunez, Rene, Odetalla, Ramzey, Bari, Mohammed A, Bitter, Istvan, Feldman, Peter D, (Cathy) Liu, I-Yuan, Stankovic, Srdjan
Publicado 2020